SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-17-008679
Filing Date
2017-09-21
Accepted
2017-09-21 17:12:30
Documents
2
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1336
2 POWER OF ATTORNEY poa-dunn.htm EX-24 6087
  Complete submission text file 0001654954-17-008679.txt   9128
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VITAL THERAPIES, INC. 15010 AVENUE OF SCIENCE, SUITE 200 SAN DIEGO CA 92128
Business Address
DUNN JOHN MICHAEL (Reporting) CIK: 0001238648 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33004 | Film No.: 171096279